<scp>HERACLIS‐TAF</scp> : a multi‐centre prospective cohort study on 2‐year safety and efficacy of tenofovir alafenamide in patients with chronic hepatitis B with renal and/or bone disorders or risks-Reference-Cited by-同舟云学术

HERACLIS‐TAF : a multi‐centre prospective cohort study on 2‐year safety and efficacy of tenofovir alafenamide in patients with chronic hepatitis B with renal and/or bone disorders or risks

Published:2022-06-23 Issue:4 Volume:56 Page:702-712
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Papatheodoridis George V.¹^ORCID,Mimidis Kostas²,Manolakopoulos Spilios¹³,Gatselis Nikolaos⁴,Goulis John⁵,Kapatais Andreas⁶,Manesis Emanuel⁷,Vasiliadis Themistoklis⁸,Triantos Christos⁹^ORCID,Samonakis Dimitrios¹⁰,Sevastianos Vasilios¹¹,Karatapanis Stelios¹²,Elefsiniotis Ioannis¹³,Deutsch Melanie³,Mylopoulou Theodora²,Papatheodoridi Margarita¹,Kranidioti Hariklia³,Agorastou Polyxeni⁵,Karaoulani Theofani⁶,Kyriazidou Anastasia⁸,Zisimopoulos Konstantinos⁹,Dalekos George N.⁴

Affiliation:

1. Department of Gastroenterology Medical School of National & Kapodistrian University of Athens Athens Greece

2. Α' Department of Internal Medicine Democritus University of Thrace Alexandroupolis Greece

3. 2nd Department of Internal Medicine Medical School of National & Kapodistrian University of Athens Hippokratio General Hospital of Athens Athens Greece

4. Department of Medicine and Research Laboratory of Internal Medicine, National and European (ERN‐Rare Liver) Expertise Center in Autoimmune Liver Diseases General University Hospital of Larissa Larissa Greece

5. 4th Department of Internal Medicine, Hippokratio Hospital Aristotle University of Thessaloniki Thessaloniki Greece

6. General Hospital Nikaia‐Piraeus Agios Panteleimon General Hospital of Western Attica Agia Varvara Agia Varvara Greece

7. Liver Unit Euroclinic SA Athens Greece

8. 3rd Department of Internal Medicine Aristotle University of Thessaloniki, "Papageorgiou" Hospital Thessaloniki Greece

9. Department of Gastroenterology University Hospital of Patras Patras Greece

10. University Hospital of Heraklion Crete Department of Gastroenterology & Hepatology Iraklio Greece

11. 4th Department of Internal Medicine and Liver Outpatient Clinic Evangelismos General Hospital Athens Greece

12. 1st Department of Internal Medicine General Hospital of Rhodes Rhodes Greece

13. University Department of Internal Medicine General and Oncology Hospital of Kifisia Agioi Anargyroi Athens Greece

Funder

Takeda Pharmaceuticals North America

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/apt.17093

Reference15 articles.

1. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection

2. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance

3. Tenofovir alafenamide in the treatment of chronic hepatitis B: design, development, and place in therapy

4. Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of HBeAg-positive chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial

5. Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of patients with HBeAg-negative chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Naif Kronik Hepatit B Tedavisinde Tenofovir Alafenamid: Tek Merkezli Retrospektif Çalışma;ANKEM Dergisi;2024-04-30

2. Cost–effectiveness of switching from tenofovir disoproxil fumarate to tenofovir alafenamide versus entecavir for chronic hepatitis B patients in Greece;Journal of Comparative Effectiveness Research;2024-04

3. A new approach to prevent, diagnose, and treat hepatitis B in Africa;BMC Global and Public Health;2023-11-02

4. Letter: Rethinking the lower incidence of HCC in HIV‐infected patients—A closer look at confounding factors. Authors' reply;Alimentary Pharmacology & Therapeutics;2023-10-13

5. Editorial: changes in renal function and bone mineral density after switching from tenofovir disoproxil fumarate to tenofovir alafenamide in chronic hepatitis B patients—author's reply;Alimentary Pharmacology & Therapeutics;2022-08-07